Thromboprophylaxis in Patients With Fontan Circulation.

Van den Eynde, Jef; Possner, Mathias; Alahdab, Fares; Veldtman, Gruschen; Goldstein, Bryan H; Rathod, Rahul H; Hoskoppal, Arvind K; Saraf, Anita; Feingold, Brian; Alsaied, Tarek (2023). Thromboprophylaxis in Patients With Fontan Circulation. Journal of the American College of Cardiology, 81(4), pp. 374-389. Elsevier 10.1016/j.jacc.2022.10.037

Text Thromboprophylaxis_in_Patients_With_Fontan_Circulation.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB)

BACKGROUND

The optimal strategy for thromboprophylaxis in patients with a Fontan circulation is unknown.

OBJECTIVES

The aim of this study was to compare the efficacy and safety of aspirin, warfarin, and nonvitamin K oral anticoagulants (NOACs) in a network meta-analysis.

METHODS

Relevant studies published by February 2022 were included. The primary efficacy outcome was thromboembolic events; major bleeding was a secondary safety outcome. Frequentist network meta-analyses were conducted to estimate the incidence rate ratios (IRRs) of both outcomes. Ranking of treatments was performed based on probability (P) score.

RESULTS

A total of 21 studies were included (26,546 patient-years). When compared with no thromboprophylaxis, NOAC (IRR: 0.11; 95% CI: 0.03-0.40), warfarin (IRR: 0.23; 95% CI: 0.14-0.37), and aspirin (IRR: 0.24; 95% CI: 0.15-0.39) were all associated with significantly lower rates of thromboembolic events. However, the network meta-analysis revealed no significant differences in the rates of major bleeding (NOAC: IRR: 1.45 [95% CI: 0.28-7.43]; warfarin: IRR: 1.38 [95% CI: 0.41-4.69]; and aspirin: IRR: 0.72 [95% CI: 0.20-2.58]). Rankings, which simultaneously analyze competing interventions, suggested that NOACs have the highest P score to prevent thromboembolic events (P score 0.921), followed by warfarin (P score 0.582), aspirin (P score 0.498), and no thromboprophylaxis (P score 0.001). Aspirin tended to have the most favorable overall profile.

CONCLUSIONS

Aspirin, warfarin, and NOAC are associated with lower risk of thromboembolic events. Recognizing the limited number of patients and heterogeneity of studies using NOACs, the results support the safety and efficacy of NOACs in patients with a Fontan circulation.

Interest & Impact

Downloads

1 since deposited on 04 Jan 2024
1 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item